Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|April 30, 2021
The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt LeukemiaErica Dander, Chiara Palmi, Giovanna D'Amico, et al.
Cancer Research|January 4, 2008
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cellsGrazia Fazio, Chiara Palmi, Antonius Rolink, et al.
Cancer Letters|November 29, 2005
TEL/ARG induces cytoskeletal abnormalities in 293T cellsChiara Palmi, Grazia Fazio, Arianna Cassetti, et al.
Experimental Hematology|March 3, 2019
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemiaFederica Portale, Linda Beneforti, Alessandra Fallati, et al.
The Journal of Clinical Investigation|March 17, 2009
The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cellsAnthony M Ford, Chiara Palmi, Clara Bueno, et al.
Cell Death Discovery|March 12, 2026
Targeting oncogene-induced senescence in ETV6::RUNX1 pre-leukemic cellsDenise Acunzo, Mayla Bertagna, Giulia Risca, et al.
Haematologica|April 16, 2013
What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?Chiara Palmi, Maria Grazia Valsecchi, Giulia Longinotti, et al.
Haematologica|April 16, 2026
Efficacy of the kinase inhibitor CHZ868 against JAK2 rearrangements in pediatric acute lymphoblastic leukemiaManuel Quadri, Claudia Saitta, Sonia Palamini, et al.
Oncotarget|February 16, 2015
Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical modelMd Nabiul Hasan, Manon Queudeville, Luca Trentin, et al.
Heliyon|July 29, 2024
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screeningAthanasios Oikonomou, Titus Watrin, Luigia Valsecchi, et al.
Pageof 3